Overweight or obese Clinical Trials

11 recruitingLast updated: May 13, 2026

There are 11 actively recruiting overweight or obese clinical trials across 4 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Melbourne, Victoria, Australia, Chengdu, Sichuan, China, Columbia, South Carolina, United States. Updated daily from ClinicalTrials.gov.


Overweight or obese Trials at a Glance

11 actively recruiting trials for overweight or obese are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Melbourne, Chengdu, and Columbia. Lead sponsors running overweight or obese studies include BrightGene Bio-Medical Technology Co., Ltd., Australian Catholic University, and Alveus Therapeutics, Inc..

Browse overweight or obese trials by phase

Treatments under study

About Overweight or obese Clinical Trials

Looking for clinical trials for Overweight or obese? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Overweight or obese trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Overweight or obese clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial

Overweight or obeseCHD
Guangdong Provincial People's Hospital140 enrolled1 locationNCT07514611
Recruiting
Not Applicable

Time-Restricted Eating for Weight-Loss Maintenance

Overweight or Obese Adults
Harbin Medical University500 enrolled10 locationsNCT07163455
Recruiting
Phase 1

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes
Alveus Therapeutics, Inc.180 enrolled1 locationNCT07399678
Recruiting
Not Applicable

Pistachio Snacking and Metabolic Flexibility

Overweight or obeseHealthy ParticipantsObese Patients (BMI ≥ 30 kg/m²)+4 more
University of South Carolina60 enrolled1 locationNCT07340125
Recruiting
Phase 1

A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects

HealthyNon-diabetic Overweight or Obese
BrightGene Bio-Medical Technology Co., Ltd.75 enrolled1 locationNCT07239973
Recruiting
Phase 1

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

Non-diabetic Overweight or Obese
BrightGene Bio-Medical Technology Co., Ltd.80 enrolled1 locationNCT07166081
Recruiting
Not Applicable

Effect of a Liquid Tonic Drink on Post-meal Glucose and Insulin Responses

Overweight or Obese Adults
Australian Catholic University20 enrolled1 locationNCT07030010
Recruiting
Phase 2

Phase II Study of THDBH120 Injection in Overweight or Obese Subjects

Overweight or obese
Tonghua Dongbao Pharmaceutical Co.,Ltd276 enrolled1 locationNCT07036601
Recruiting
Not Applicable

Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)

Kidney TransplantOverweight or Obese AdultsGlucose Control
University of Kansas Medical Center60 enrolled1 locationNCT06640179
Recruiting
Phase 1

A Study to Evaluate MWN109 Injection in Healthy Subjects

Overweight or obese
Shanghai Minwei Biotechnology Co., Ltd72 enrolled1 locationNCT06859853
Recruiting

The 6-minute Pegboard and Ring Test in Overweight and Obese Individuals

Overweight or Obese Adults
Kirsehir Ahi Evran Universitesi24 enrolled1 locationNCT06742112